Wei Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Wei Wang has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
- Feilong Zhou
State Key Laboratory of Medicinal Chemical Biology and College of Life Science, Nankai University, Tianjin, China
2 shared publications Hongkai Zhang
State Key Laboratory of Medicinal Chemical Biology and College of Life Science, Nankai University, Tianjin, China
2 shared publications- Na Li
State Key Laboratory of Medicinal Chemical Biology and College of Life Science, Nankai University, Tianjin, China
2 shared publications - Youjia Cao
State Key Laboratory of Medicinal Chemical Biology and College of Life Science, Nankai University, Tianjin, China; Nankai International Advanced Research Institute (Shenzhen Futian), Nankai University, Shenzhen, China
2 shared publications - Bingqing Shen
HiFiBiO, Inc., 237 Putnam Avenue, Cambridge, MA 02139, USA
1 shared publication Chunlei Wang
State Key Laboratory of Medicinal Chemical Biology and College of Life Science, Nankai University, Tianjin, China
1 shared publication
Latest Publications
- 18 January 2024
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 698, 149546
Reprogramming macrophage by targeting VEGF and CD40 potentiates OX40 immunotherapy
- 18 January 2024
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 698, 149546
Reprogramming macrophage by targeting VEGF and CD40 potentiates OX40 immunotherapy
- Open Access
- 11 June 2021
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 7 (24) , eabe3839
High-throughput functional screening for next-generation cancer immunotherapy using droplet-based microfluidics
Microfluidics system enables high-throughput functional screening of antibodies for cancer immunotherapy.
- 11 June 2021
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 7 (24) , eabe3839
Open AccessHigh-throughput functional screening for next-generation cancer immunotherapy using droplet-based microfluidics
Microfluidics system enables high-throughput functional screening of antibodies for cancer immunotherapy.